Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2 to the site. Removed older notices including the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check13 days agoChange DetectedAdded a government funding notice at the top of the page and updated the site version to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedShow glossary added, revision updated to v3.4.0, and labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with capitalization changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page. There are no substantive changes to the study details, eligibility criteria, or outcomes visible in the screenshots.SummaryDifference0.1%

- Check56 days agoChange DetectedA new Locations section listing Connecticut and Florida was added, replacing the separate Connecticut Locations and Florida Locations sections, and revision tags updated from v3.3.2 to v3.3.3.SummaryDifference0.3%

- Check85 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not relate to the study, and the page revision number has been updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.